A study of the effect of Synbiotic Supplement in Gastrointestinal Symptoms and Quality of Life in Patient with Celiac Disease: a randomized double blinded clinical trial

Phase 3

• Conditions: K90.0; Patients with celiac disease.; Celiac disease

• Registration Number: IRCT20210717051916N1
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

Definitive diagnosis of celiac disease based on test results and specialist diagnosis

Exclusion Criteria

pregnancy- Breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gastrointestinal symptoms of patients before and after taking the supplement. Timepoint: At the beginning of the study (before the intervention) and 12 weeks later. Method of measurement: Gastrointestinal Symptom Rating Scale questionnaire (GSRS).

Secondary Outcome Measures

Name	Time	Method
Quality of life of patients. Timepoint: At the beginning of the study (before the intervention) and 12 weeks later. Method of measurement: The celiac disease quality of life questionnaire (CDQOL).